Skip to main content

Immunovant, Inc.

IMVT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001764013

In the last 90 days, Immunovant, Inc. insiders filed 0 open-market purchases and 10 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.25B in total; Greenlight Capital is the only superinvestor holding it.

13F holders, Q4 2021

Institutional positions in Immunovant, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
118
+1 vs. Q3 2021
Shares held
37.8M
+4.12M (+12.2%) vs. Q3 2021
Total value
$322.4M
+$29.3M (+10.0%) vs. Q3 2021
New holders
21
40 more added
Sold out
20
45 more reduced

2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting IMVT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 118 institutions
Q1 2021: 120 institutionsQ2 2021: 110 institutionsQ3 2021: 119 institutionsQ4 2021: 118 institutionsQ1 2022: 112 institutionsQ2 2022: 94 institutionsQ3 2022: 112 institutionsQ4 2022: 133 institutionsQ1 2023: 142 institutionsQ2 2023: 147 institutionsQ3 2023: 181 institutionsQ4 2023: 228 institutionsQ1 2024: 209 institutionsQ2 2024: 197 institutionsQ3 2024: 182 institutionsQ4 2024: 187 institutionsQ1 2025: 194 institutionsQ2 2025: 169 institutionsQ3 2025: 186 institutionsQ4 2025: 197 institutionsQ1 2026: 216 institutionsQ2 2026: 226 institutions
Value heldQ4 2021: $322.4M
Q1 2021: $654.3MQ2 2021: $407.5MQ3 2021: $293.6MQ4 2021: $322.4MQ1 2022: $218.6MQ2 2022: $156.5MQ3 2022: $238.1MQ4 2022: $1.00BQ1 2023: $903.7MQ2 2023: $1.05BQ3 2023: $2.57BQ4 2023: $2.88BQ1 2024: $2.27BQ2 2024: $1.97BQ3 2024: $2.26BQ4 2024: $1.98BQ1 2025: $1.62BQ2 2025: $1.54BQ3 2025: $1.53BQ4 2025: $2.76BQ1 2026: $2.75BQ2 2026: $4.25B
Institutions holding IMVT and their total value by quarter
QuarterHoldersValue
Q2 2026226$4.25B
Q1 2026216$2.75B
Q4 2025197$2.76B
Q3 2025186$1.53B
Q2 2025169$1.54B
Q1 2025194$1.62B
Q4 2024187$1.98B
Q3 2024182$2.26B
Q2 2024197$1.97B
Q1 2024209$2.27B
Q4 2023228$2.88B
Q3 2023181$2.57B
Q2 2023147$1.05B
Q1 2023142$903.7M
Q4 2022133$1.00B
Q3 2022112$238.1M
Q2 202294$156.5M
Q1 2022112$218.6M
Q4 2021118$322.4M
Q3 2021119$293.6M
Q2 2021110$407.5M
Q1 2021120$654.3M

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Immunovant, Inc.; share changes are against Q3 2021.

Institutions holding IMVT in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Northern Trust Corp389,396$3.32M0.00%−1,649−0.4%Reduced
Morgan Stanley496,910$4.23M0.00%−368,336−42.6%Reduced
Federated Hermes, Inc.499,490$4.26M0.01%+486,456+3,732.2%Added
Octagon Capital Advisors LP572,862$4.88M0.95%+572,862New
Frazier Management LLC585,759$4.99M0.38%00.0%Unchanged
Platinum Investment Management Ltd615,900$5.25M0.15%+60,835+11.0%Added
Mangrove Partners688,000$5.86M0.43%+188,000+37.6%Added
Two Sigma Advisers, LP732,300$6.24M0.02%−276,200−27.4%Reduced
Geode Capital Management, LLC820,399$6.99M0.00%−35,509−4.1%Reduced
Two Sigma Investments, LP853,528$7.27M0.02%−290,783−25.4%Reduced
Point72 Asset Management, L.P.900,500$7.67M0.03%+900,500New
EcoR1 Capital, LLC1,140,819$9.72M0.31%00.0%Unchanged
State Street Corp2,782,794$23.7M0.00%−1,329,000−32.3%Reduced
Alpine Global Management, LLC3,007,000$25.6M3.81%+6,800+0.2%Added
BlackRock Inc.3,325,001$28.3M0.00%+76,000+2.3%Added
Vanguard Group Inc3,834,119$32.7M0.00%+84,833+2.3%Added
Deep Track Capital, LP4,775,000$40.7M3.01%+4,775,000New
Eventide Asset Management, LLC4,950,000$42.2M0.54%00.0%Unchanged
American Century Companies Inc0$00.00%−250,854−100.0%Sold out
Woodline Partners LP0$00.00%−241,599−100.0%Sold out
Ikarian Capital, LLC0$00.00%−83,046−100.0%Sold out
Winton Group Ltd0$00.00%−47,575−100.0%Sold out
Boothbay Fund Management, LLC0$00.00%−32,233−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−24,400−100.0%Sold out
Price T Rowe Associates Inc0$00.00%−22,680−100.0%Sold out
Trexquant Investment LP0$00.00%−18,198−100.0%Sold out
Dynamic Technology Lab Private Ltd0$00.00%−17,376−100.0%Sold out
XTX Topco Ltd0$00.00%−15,418−100.0%Sold out
Blueshift Asset Management, LLC0$00.00%−13,393−100.0%Sold out
E Fund Management Co., Ltd.0$00.00%−10,474−100.0%Sold out
Advisory Services Network, LLC0$00.00%−10,300−100.0%Sold out
Vontobel Holding Ltd.0$00.00%−10,000−100.0%Sold out
Belvedere Trading LLC0$00.00%−6,621−100.0%Sold out
Atlas Capital Advisors LLC0$00.00%−1,000−100.0%Sold out
Dark Forest Capital Management LP0$00.00%−578−100.0%Sold out
Red Tortoise LLC0$00.00%−350−100.0%Sold out
Tarbox Family Office, Inc.0$00.00%−127−100.0%Sold out
Quadrant Capital Group LLC0$00.00%−74−100.0%Sold out
Knott David M––––Not filed
Marshall Wace North America L.P.––––Not filed